Biofrontera Inc. (BFRI) vs Rockwell Medical, Inc. (RMTI)
Biofrontera Inc. and Rockwell Medical, Inc. are both Drug Manufacturers Specialty & Generic companies. Rockwell Medical, Inc. is the larger, with a market value of $34.5M against $17.8M — 1.9× the size. Biofrontera Inc. grew revenue faster over the last twelve months: 17.8% against −21.1%. Rockwell Medical, Inc. has the higher net margin (−7.33% vs −13.8%) and the higher return on invested capital (−14.6% vs −69.5%). Across the 18 metrics below, Rockwell Medical, Inc. leads on 12 and Biofrontera Inc. on 6.
Valuation
Profitability
| Metric | BFRI | RMTI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 79.25% | 17.71% | 53.94% |
| Operating margin | (14.22%) | (6.52%) | 0.00% |
| Net margin | (13.78%) | (7.33%) | 0.00% |
| Free cash flow margin | (17.17%) | 2.47% | 0.00% |
| Return on equity | (988.35%) | (15.53%) | (0.40%) |
| Return on assets | (28.80%) | (9.32%) | (3.32%) |
| Return on invested capital | (69.45%) | (14.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack